AFT Forsyth & Company’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $700K | Buy |
4,147
+1
| +0% | +$171 | 0.33% | 64 |
|
|
2025
Q4 | $700K | Sell |
4,146
-17
| -0.4% | -$2.76K | 0.3% | 65 |
|
|
2025
Q3 | $601K | Sell |
4,163
-43
| -1% | -$5.87K | 0.29% | 65 |
|
|
2025
Q2 | $532K | Sell |
4,206
-5
| -0.1% | -$614 | 0.27% | 66 |
|
|
2025
Q1 | $539K | Buy |
4,211
+2
| +0% | +$271 | 0.29% | 74 |
|
|
2024
Q4 | $556K | Sell |
4,209
-153
| -4% | -$21.5K | 0.27% | 76 |
|
|
2024
Q3 | $635K | Sell |
4,362
-32
| -0.7% | -$4.63K | 0.31% | 71 |
|
|
2024
Q2 | $603K | Buy |
4,394
+30
| +0.7% | +$4K | 0.3% | 76 |
|
|
2024
Q1 | $599K | Buy |
4,364
+108
| +3% | +$14.7K | 0.34% | 71 |
|
|
2023
Q4 | $578K | Sell |
4,256
-387
| -8% | -$47.2K | 0.36% | 71 |
|
|
2023
Q3 | $568K | Sell |
4,643
-5
| -0.1% | -$636 | 0.42% | 64 |
|
|
2023
Q2 | $590K | Sell |
4,648
-385
| -8% | -$50K | 0.42% | 65 |
|
|
2023
Q1 | $650K | Buy |
5,033
+56
| +1% | +$7.33K | 0.5% | 60 |
|
|
2022
Q4 | $653K | Buy |
4,977
+141
| +3% | +$18.2K | 0.56% | 57 |
|
|
2022
Q3 | $566K | Buy |
4,836
+115
| +2% | +$14.3K | 0.51% | 59 |
|
|
2022
Q2 | $555K | Buy |
4,721
+1
| +0% | +$119 | 0.45% | 64 |
|
|
2022
Q1 | $615K | Sell |
4,720
-68
| -1% | -$8.86K | 0.39% | 71 |
|
|
2021
Q4 | $731K | Buy |
4,788
+31
| +0.7% | +$4.8K | 0.38% | 80 |
|
|
2021
Q3 | $769K | Buy |
4,757
+60
| +1% | +$10.1K | 0.41% | 73 |
|
|
2021
Q2 | $769K | Buy |
4,697
+65
| +1% | +$10K | 0.41% | 83 |
|
|
2021
Q1 | $697K | Buy |
4,632
+30
| +0.7% | +$4.76K | 0.42% | 83 |
|
|
2020
Q4 | $697K | Buy |
4,602
+95
| +2% | +$13.6K | 0.44% | 81 |
|
|
2020
Q3 | $610K | Buy |
4,507
+331
| +8% | +$44.9K | 0.45% | 70 |
|
|
2020
Q2 | $571K | Buy |
4,176
+75
| +2% | +$9.56K | 0.48% | 69 |
|
|
2020
Q1 | $442K | Sell |
4,101
-53
| -1% | -$6.1K | 0.44% | 76 |
|
|
2019
Q4 | $501K | Buy |
4,154
+125
| +3% | +$13.9K | 0.38% | 87 |
|
|
2019
Q3 | $401K | Sell |
4,029
-120
| -3% | -$12.6K | 0.33% | 99 |
|
|
2019
Q2 | $453K | Hold |
4,149
| – | – | 0.37% | 88 |
|
|
2019
Q1 | $464K | Hold |
4,149
| – | – | 0.4% | 89 |
|
|
2018
Q4 | $400K | Sell |
4,149
-90
| -2% | -$9.55K | 0.4% | 88 |
|
|
2018
Q3 | $517K | Hold |
4,239
| – | – | 0.43% | 85 |
|
|
2018
Q2 | $466K | Sell |
4,239
-90
| -2% | -$9.63K | 0.41% | 90 |
|
|
2018
Q1 | $462K | Hold |
4,329
| – | – | 0.43% | 85 |
|
|
2017
Q4 | $462K | Buy |
+4,329
| New | +$463K | 0.45% | 76 |
|
|
2013
Q3 | $132K | Buy |
1,884
+744
| +65% | +$48.7K | 0.17% | 126 |
|
|
2013
Q2 | $66K | Buy |
+1,140
| New | +$65.9K | 0.09% | 148 |
|
Other funds holding IBB
CB
AFT Forsyth & Company's IBB Position: Q1 2026 in Review
AFT Forsyth & Company increased its iShares Biotechnology ETF (IBB) stake by 0.02% in Q1 2026, buying an estimated $171 and bringing the position to 4,147 shares worth $700K. The position accounts for 0.33% of the portfolio, ranked #64.
AFT Forsyth & Company first reported a position in IBB in Q2 2013 and has held it in 36 quarters since. The position peaked at $769K in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- AFT Forsyth & Company held 4,147 shares of iShares Biotechnology ETF worth $700K as of Q1 2026.
- AFT Forsyth & Company bought 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
- iShares Biotechnology ETF made up 0.33% of AFT Forsyth & Company's portfolio in Q1 2026, its #64 holding.
- AFT Forsyth & Company first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 36 quarters since.
- AFT Forsyth & Company's iShares Biotechnology ETF position peaked at $769K in Q3 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on AFT Forsyth & Company's 13F filing for Q1 2026, filed 14 May 2026.